HCAT Health Catalyst, Inc.
Nasdaq · SEC CIK 1636422 · EDGAR
- Bought, last 12 months
- $105.4K 1 purchases by 1 insiders
- Sold, last 12 months
- $200.6K 2 sales by 2 insiders
- Filings on record
- 343 since 2021-07-06, latest 2026-09-16 16:52
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Larson-Green Julie | Dir | — | $128.2K |
| Kohl Simeon | CEO, Dir | $105.4K | — |
| Landry Benjamin | GC | — | $72.4K |
| Albert Benjamin | CEO, Dir | — | — |
| Hoggard Green Jill | Dir | — | — |
| Freeman Kevin Lee | Chief Commercial Off | — | — |
| Alger Jason | CFO | — | — |
| Burton Daniel D. | CEO, Dir | — | — |
| Gallagher Duncan | Dir | — | — |
| Llewelyn Linda | CHRO | — | — |
Transactions 414
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-03-03 | 2022-03-01 | HCAT | Nelli James Patrick Jr. | Pres | A - Grant | $0.00 | +11.5K | 264.0K | +5% | $0 |
| M | 2022-03-03 | 2022-03-01+ | HCAT | Nelli James Patrick Jr. | Pres | F - Tax | $26.64 | -4,792 | 260.9K | -2% | -$127.7K |
| M | 2022-03-03 | 2022-03-01+ | HCAT | Alger Jason | CAO | F - Tax | $26.64 | -1,119 | 38.6K | -3% | -$29.8K |
| 2022-03-03 | 2022-03-01 | HCAT | Alger Jason | CAO | A - Grant | $0.00 | +1,551 | 38.8K | +4% | $0 | |
| M | 2022-03-03 | 2022-03-01+ | HCAT | Llewelyn Linda | CHRO | F - Tax | $26.64 | -1,414 | 66.3K | -2% | -$37.7K |
| 2022-03-03 | 2022-03-01 | HCAT | Llewelyn Linda | CHRO | A - Grant | $0.00 | +1,861 | 66.5K | +3% | $0 | |
| M | 2022-03-03 | 2022-03-01+ | HCAT | Horstmeier Paul | COO | F - Tax | $26.64 | -3,506 | 196.4K | -2% | -$93.4K |
| 2022-03-03 | 2022-03-01 | HCAT | Horstmeier Paul | COO | A - Grant | $0.00 | +3,164 | 196.8K | +2% | $0 | |
| 2022-02-28 | 2022-02-24 | HCAT | Orenstein Daniel H. | GC | A - Grant | $0.00 | +40.0K | 106.8K | +60% | $0 | |
| 2022-02-28 | 2022-02-24 | HCAT | Alger Jason | CAO | A - Grant | $0.00 | +25.0K | 38.2K | +189% | $0 | |
| 2022-02-28 | 2022-02-24 | HCAT | Nelli James Patrick Jr. | Pres | A - Grant | $0.00 | +110.0K | 265.0K | +71% | $0 | |
| 2022-02-28 | 2022-02-24 | HCAT | Llewelyn Linda | CHRO | A - Grant | $0.00 | +35.0K | 65.9K | +113% | $0 | |
| 2022-02-28 | 2022-02-24 | HCAT | Hinton Bryan Richard | CTO | A - Grant | $0.00 | +20.0K | 29.4K | +213% | $0 | |
| 2022-02-28 | 2022-02-24 | HCAT | Horstmeier Paul | COO | A - Grant | $0.00 | +100.0K | 196.7K | +103% | $0 | |
| 2022-02-28 | 2022-02-24 | HCAT | Burton Daniel D. | CEO, Dir | A - Grant | $0.00 | +125.0K | 361.9K | +53% | $0 | |
| 2022-02-28 | 2022-02-24 | HCAT | Hunt Bryan Truman | CFO | A - Grant | $0.00 | +100.0K | 156.3K | +178% | $0 | |
| DM | 2022-02-16 | 2022-02-14 | HCAT | Nelli James Patrick Jr. | Pres | M - OptEx | $10.67 | +14.1K | 155.0K | +10% | +$150.0K |
| DM | 2022-02-09 | 2022-02-07 | HCAT | Horstmeier Paul | COO | M - OptEx | $12.45 | +10.8K | 100.9K | +12% | +$133.8K |
| DM | 2022-02-09 | 2022-02-07 | HCAT | Horstmeier Paul | COO | S - Sale+OE | $29.10 | -10.8K | 100.2K | -10% | -$312.9K |
| D | 2022-02-03 | 2022-02-01 | HCAT | Llewelyn Linda | CHRO | S - Sale+OE | $30.00 | -1,100 | 30.9K | -3% | -$33.0K |
| D | 2022-02-03 | 2022-02-01 | HCAT | Llewelyn Linda | CHRO | M - OptEx | $10.80 | +1,100 | 32.0K | +4% | +$11.9K |
| DM | 2022-01-06 | 2022-01-05 | HCAT | Horstmeier Paul | COO | M - OptEx | $15.84 | +10.8K | 100.8K | +12% | +$170.3K |
| DM | 2022-01-06 | 2022-01-05 | HCAT | Horstmeier Paul | COO | S - Sale+OE | $36.78 | -10.8K | 98.2K | -10% | -$395.3K |
| D | 2022-01-06 | 2022-01-04 | HCAT | Llewelyn Linda | CHRO | S - Sale+OE | $40.23 | -3,234 | 30.9K | -9% | -$130.1K |
| DM | 2022-01-06 | 2022-01-04 | HCAT | Llewelyn Linda | CHRO | M - OptEx | $11.14 | +3,150 | 34.1K | +10% | +$35.1K |
| D | 2022-01-05 | 2022-01-03 | HCAT | Hinton Bryan Richard | CTO | M - OptEx | $10.78 | +106 | 9,481 | +1% | +$1,143 |
| D | 2022-01-05 | 2022-01-03 | HCAT | Hinton Bryan Richard | CTO | S - Sale+OE | $39.76 | -106 | 9,375 | -1% | -$4,215 |
| MA | 2021-12-29 | 2021-12-07 | HCAT | Horstmeier Paul | COO | S - Sale | $40.07 | -2,482 | 97.1K | -2% | -$99.5K |
| DMA | 2021-12-29 | 2021-12-06 | HCAT | Horstmeier Paul | COO | S - Sale+OE | $39.20 | -6,063 | 104.6K | -5% | -$237.7K |
| DA | 2021-12-29 | 2021-12-06 | HCAT | Horstmeier Paul | COO | M - OptEx | $15.84 | +6,063 | 105.2K | +6% | +$96.0K |
| D | 2021-12-29 | 2021-12-27 | HCAT | Hinton Bryan Richard | CTO | M - OptEx | $10.80 | +260 | 9,635 | +3% | +$2,808 |
| D | 2021-12-29 | 2021-12-27 | HCAT | Hinton Bryan Richard | CTO | S - Sale+OE | $39.56 | -260 | 9,375 | -3% | -$10.3K |
| DM | 2021-12-15 | 2021-12-13 | HCAT | Nelli James Patrick Jr. | Pres | M - OptEx | $9.77 | +25.0K | 119.0K | +27% | +$244.2K |
| M | 2021-12-09 | 2021-12-07 | HCAT | Horstmeier Paul | COO | S - Sale | $40.07 | -2,482 | 90.6K | -3% | -$99.5K |
| D | 2021-12-09 | 2021-12-07 | HCAT | Burton Daniel D. | CEO, Dir | M - OptEx | $10.80 | +15.5K | 252.4K | +7% | +$167.7K |
| D | 2021-12-09 | 2021-12-07 | HCAT | Burton Daniel D. | CEO, Dir | S - Sale+OE | $40.47 | -15.5K | 236.9K | -6% | -$628.5K |
| DM | 2021-12-07 | 2021-12-03+ | HCAT | Hinton Bryan Richard | CTO | S - Sale+OE | $38.51 | -6,562 | 14.4K | -31% | -$252.7K |
| D | 2021-12-07 | 2021-12-03 | HCAT | Hinton Bryan Richard | CTO | M - OptEx | $10.78 | +105 | 15.9K | +0.7% | +$1,132 |
| D | 2021-12-07 | 2021-12-02 | HCAT | Hinton Bryan Richard | CTO | F - Tax | $41.95 | -2,918 | 15.8K | -16% | -$122.4K |
| 2021-12-07 | 2021-12-02 | HCAT | Alger Jason | CAO | F - Tax | $41.95 | -1,460 | 13.9K | -10% | -$61.2K | |
| 2021-12-07 | 2021-12-06 | HCAT | Alger Jason | CAO | S - Sale | $38.83 | -644 | 13.2K | -5% | -$25.0K | |
| 2021-12-07 | 2021-12-02 | HCAT | Nelli James Patrick Jr. | Pres | F - Tax | $41.95 | -11.2K | 115.9K | -9% | -$468.7K | |
| M | 2021-12-07 | 2021-12-06 | HCAT | Horstmeier Paul | COO | S - Sale | $39.20 | -6,063 | 98.6K | -6% | -$237.7K |
| 2021-12-07 | 2021-12-02 | HCAT | Horstmeier Paul | COO | F - Tax | $41.95 | -9,261 | 99.2K | -9% | -$388.5K | |
| DM | 2021-12-07 | 2021-12-03+ | HCAT | Orenstein Daniel H. | GC | S - Sale+OE | $39.93 | -7,133 | 71.4K | -9% | -$284.8K |
| D | 2021-12-07 | 2021-12-02 | HCAT | Orenstein Daniel H. | GC | F - Tax | $41.95 | -4,117 | 71.4K | -5% | -$172.7K |
| D | 2021-12-07 | 2021-12-03 | HCAT | Orenstein Daniel H. | GC | M - OptEx | $10.34 | +2,500 | 73.9K | +3% | +$25.9K |
| 2021-12-07 | 2021-12-02 | HCAT | Hunt Bryan Truman | CFO | F - Tax | $41.95 | -4,960 | 56.3K | -8% | -$208.1K | |
| DM | 2021-12-07 | 2021-12-03 | HCAT | Llewelyn Linda | CHRO | M - OptEx | $11.29 | +2,200 | 32.8K | +7% | +$24.8K |
| DM | 2021-12-07 | 2021-12-03+ | HCAT | Llewelyn Linda | CHRO | S - Sale+OE | $40.52 | -2,943 | 31.0K | -9% | -$119.2K |
| D | 2021-12-07 | 2021-12-02 | HCAT | Llewelyn Linda | CHRO | F - Tax | $41.95 | -2,839 | 31.7K | -8% | -$119.1K |
| DM | 2021-12-07 | 2021-12-03+ | HCAT | Burton Daniel D. | CEO, Dir | M - OptEx | $12.72 | +53.2K | 278.1K | +24% | +$677.1K |
| DM | 2021-12-07 | 2021-12-03+ | HCAT | Burton Daniel D. | CEO, Dir | S - Sale+OE | $40.41 | -58.2K | 241.9K | -19% | -$2.35M |
| D | 2021-12-07 | 2021-12-02 | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $41.95 | -4,410 | 241.9K | -2% | -$185.0K |
| D | 2021-11-30 | 2021-11-26 | HCAT | Hinton Bryan Richard | CTO | S - Sale+OE | $44.10 | -260 | 18.8K | -1% | -$11.5K |
| D | 2021-11-30 | 2021-11-26 | HCAT | Hinton Bryan Richard | CTO | M - OptEx | $10.80 | +260 | 19.0K | +1% | +$2,808 |
| 2021-11-15 | 2021-11-12 | HCAT | Hunt Bryan Truman | CFO | S - Sale | $49.40 | -957 | 61.3K | -2% | -$47.3K | |
| D | 2021-11-09 | 2021-11-05 | HCAT | Horstmeier Paul | COO | M - OptEx | $15.84 | +10.8K | 119.2K | +10% | +$170.3K |
| DM | 2021-11-09 | 2021-11-05 | HCAT | Horstmeier Paul | COO | S - Sale+OE | $51.97 | -10.8K | 108.4K | -9% | -$558.7K |
| D | 2021-11-08 | 2021-11-03 | HCAT | Hinton Bryan Richard | CTO | M - OptEx | $10.78 | +106 | 18.9K | +0.6% | +$1,143 |
| D | 2021-11-08 | 2021-11-03 | HCAT | Hinton Bryan Richard | CTO | S - Sale+OE | $52.62 | -106 | 18.8K | -0.6% | -$5,578 |
| DM | 2021-11-02 | 2021-11-01 | HCAT | Llewelyn Linda | CHRO | M - OptEx | $11.13 | +3,300 | 36.7K | +10% | +$36.7K |
| DM | 2021-11-02 | 2021-11-01 | HCAT | Llewelyn Linda | CHRO | S - Sale+OE | $53.60 | -3,300 | 35.1K | -9% | -$176.9K |
| DM | 2021-11-02 | 2021-11-01 | HCAT | Orenstein Daniel H. | GC | S - Sale+OE | $53.58 | -2,500 | 75.7K | -3% | -$133.9K |
| D | 2021-11-02 | 2021-11-01 | HCAT | Orenstein Daniel H. | GC | M - OptEx | $10.34 | +2,500 | 78.0K | +3% | +$25.9K |
| D | 2021-10-27 | 2021-10-25 | HCAT | Hinton Bryan Richard | CTO | M - OptEx | $10.80 | +260 | 19.0K | +1% | +$2,808 |
| D | 2021-10-27 | 2021-10-25 | HCAT | Hinton Bryan Richard | CTO | S - Sale+OE | $50.66 | -260 | 18.8K | -1% | -$13.2K |
| D | 2021-10-07 | 2021-10-05 | HCAT | Horstmeier Paul | COO | M - OptEx | $15.84 | +10.8K | 119.2K | +10% | +$170.3K |
| DM | 2021-10-07 | 2021-10-05 | HCAT | Horstmeier Paul | COO | S - Sale+OE | $48.09 | -10.8K | 109.4K | -9% | -$517.0K |
| D | 2021-10-05 | 2021-10-01 | HCAT | Orenstein Daniel H. | GC | M - OptEx | $10.34 | +2,500 | 78.0K | +3% | +$25.9K |
| D | 2021-10-05 | 2021-10-01 | HCAT | Orenstein Daniel H. | GC | S - Sale+OE | $49.21 | -2,500 | 75.5K | -3% | -$123.0K |
| DM | 2021-10-05 | 2021-10-01 | HCAT | Llewelyn Linda | CHRO | S - Sale+OE | $49.46 | -3,259 | 34.5K | -9% | -$161.2K |
| DM | 2021-10-05 | 2021-10-01 | HCAT | Llewelyn Linda | CHRO | M - OptEx | $11.48 | +3,150 | 36.9K | +9% | +$36.2K |
| D | 2021-10-05 | 2021-10-04 | HCAT | Hinton Bryan Richard | CTO | M - OptEx | $10.78 | +106 | 18.9K | +0.6% | +$1,143 |
| D | 2021-10-05 | 2021-10-04 | HCAT | Hinton Bryan Richard | CTO | S - Sale+OE | $49.00 | -106 | 18.8K | -0.6% | -$5,194 |
| D | 2021-09-29 | 2021-09-27 | HCAT | Hinton Bryan Richard | CTO | S - Sale+OE | $53.41 | -260 | 18.8K | -1% | -$13.9K |
| D | 2021-09-29 | 2021-09-27 | HCAT | Hinton Bryan Richard | CTO | M - OptEx | $10.80 | +260 | 19.0K | +1% | +$2,808 |
| DM | 2021-09-15 | 2021-09-13 | HCAT | Nelli James Patrick Jr. | Pres | M - OptEx | $10.78 | +26.0K | 156.5K | +20% | +$280.2K |
| DM | 2021-09-15 | 2021-09-13 | HCAT | Nelli James Patrick Jr. | Pres | S - Sale+OE | $54.77 | -29.4K | 131.7K | -18% | -$1.61M |
| D | 2021-09-08 | 2021-09-03 | HCAT | Orenstein Daniel H. | GC | M - OptEx | $10.34 | +2,500 | 79.4K | +3% | +$25.9K |
| D | 2021-09-08 | 2021-09-03 | HCAT | Orenstein Daniel H. | GC | S - Sale+OE | $54.32 | -3,852 | 75.5K | -5% | -$209.2K |
| DM | 2021-09-08 | 2021-09-03+ | HCAT | Burton Daniel D. | CEO, Dir | S - Sale+OE | $54.46 | -73.8K | 256.6K | -22% | -$4.02M |
| DM | 2021-09-08 | 2021-09-03+ | HCAT | Burton Daniel D. | CEO, Dir | M - OptEx | $12.29 | +68.7K | 246.3K | +39% | +$844.9K |
| DM | 2021-09-08 | 2021-09-03 | HCAT | Llewelyn Linda | CHRO | M - OptEx | $11.29 | +2,200 | 37.8K | +6% | +$24.8K |
| D | 2021-09-08 | 2021-09-03 | HCAT | Llewelyn Linda | CHRO | S - Sale+OE | $54.27 | -3,179 | 34.7K | -8% | -$172.5K |
| DM | 2021-09-08 | 2021-09-03+ | HCAT | Hinton Bryan Richard | CTO | S - Sale+OE | $54.87 | -2,282 | 18.8K | -11% | -$125.2K |
| D | 2021-09-08 | 2021-09-03 | HCAT | Hinton Bryan Richard | CTO | M - OptEx | $10.80 | +106 | 21.0K | +0.5% | +$1,145 |
| DM | 2021-09-08 | 2021-09-07 | HCAT | Horstmeier Paul | COO | S - Sale+OE | $54.90 | -8,598 | 111.0K | -7% | -$472.0K |
| D | 2021-09-08 | 2021-09-07 | HCAT | Horstmeier Paul | COO | M - OptEx | $15.84 | +6,063 | 117.0K | +5% | +$96.0K |
| 2021-09-08 | 2021-09-03 | HCAT | Alger Jason | CAO | S - Sale | $54.23 | -652 | 15.3K | -4% | -$35.4K | |
| 2021-09-03 | 2021-09-01 | HCAT | Horstmeier Paul | COO | F - Tax | $54.23 | -2,153 | 111.0K | -2% | -$116.8K | |
| 2021-09-03 | 2021-09-01 | HCAT | Llewelyn Linda | CHRO | F - Tax | $54.23 | -475 | 35.6K | -1% | -$25.8K | |
| 2021-09-03 | 2021-09-01 | HCAT | Hunt Bryan Truman | CFO | F - Tax | $54.23 | -286 | 62.2K | -0.5% | -$15.5K | |
| 2021-09-03 | 2021-09-01 | HCAT | Alger Jason | CAO | F - Tax | $54.23 | -286 | 16.0K | -2% | -$15.5K | |
| 2021-09-03 | 2021-09-01 | HCAT | Hinton Bryan Richard | CTO | F - Tax | $54.23 | -949 | 20.9K | -4% | -$51.5K | |
| 2021-09-03 | 2021-09-01 | HCAT | Orenstein Daniel H. | GC | F - Tax | $54.23 | -1,148 | 76.9K | -1% | -$62.3K | |
| 2021-09-03 | 2021-09-01 | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $54.23 | -4,304 | 251.4K | -2% | -$233.4K | |
| 2021-09-03 | 2021-09-01 | HCAT | Nelli James Patrick Jr. | Pres | F - Tax | $54.23 | -2,870 | 130.5K | -2% | -$155.6K | |
| D | 2021-08-26 | 2021-08-25 | HCAT | Hinton Bryan Richard | CTO | M - OptEx | $10.80 | +260 | 22.1K | +1% | +$2,808 |
| D | 2021-08-26 | 2021-08-25 | HCAT | Hinton Bryan Richard | CTO | S - Sale+OE | $53.13 | -260 | 21.9K | -1% | -$13.8K |
Purchase Sale Sale after option exercise All abbreviations